Quotes GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.
Stocks
GLAXO
INE159A01016
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:08 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 2,928.20 INR | -1.00% |
|
-2.27% | +18.38% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Stock exchange
NSE India S.E.
GLAXO 2,928.20 ₹
-1.00%
148M
₹
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GLAXO | 2,928.70INR | -0.96% | 5.56M ₹ | ||
NSE India S.E.
| GLAXO | 2,928.20INR | -1.00% | 148M ₹ |
Quotes 5-day view: GlaxoSmithKline Pharmaceuticals Limited
Delayed Quote NSE India S.E.
| 2026-09-02 | 2026-09-03 | 2026-09-04 | 2026-09-07 | 2026-09-08 | |
|---|---|---|---|---|---|
| Last | ₹2,949.90 | ₹2,937.50 | ₹2,958.10 | ₹2,957.80 | ₹2,928.20 |
| Volume | 59,227 | 56,012 | 48,109 | 155,659 | 50,684 |
| Change | -1.54% | -0.42% | +0.70% | -0.01% | -1.00% |
| Opening | ₹2,972.60 | ₹2,962.40 | ₹2,938.90 | ₹2,937.90 | ₹2,978.00 |
| High | ₹2,990.10 | ₹2,998.00 | ₹2,972.80 | ₹3,075.00 | ₹3,001.30 |
| Low | ₹2,908.50 | ₹2,930.40 | ₹2,925.50 | ₹2,932.70 | ₹2,921.20 |
Performance
| 1 day | -1.00% | ||
| 1 week | -2.27% | ||
| Current month | -4.00% | ||
| 1 month | +12.64% | ||
| 3 months | +34.09% | ||
| 6 months | +16.32% | ||
| Current year | +18.38% | ||
| 1 year | +3.87% | ||
| 3 years | +100.36% | ||
| 5 years | +92.89% | ||
| 10 years | +94.99% |
Volumes
marketsDaily volume
50,684
Estimated daily volume
50,684
Avg. Volume 20 sessions
239,240
Daily volume ratio
0.21
Avg. Volume 20 sessions INR
700,542,568
Avg. Volume 20 sessions USD
7,390,023.55
Record volume 1
4,767,565
Record volume 2
3,108,044
Record volume 3
2,465,345
Capital turnover ratio
0
Basic data
Market Cap (INR)
502,141,813,496
Market Cap (USD)
5,296,653,434
Net sales (INR)
38,216,700,000
Net sales (USD)
403,114,439
Number of employees
3,103
Sales / Employee (INR)
12,316,049
Sales / Employee (USD)
129,911
Indicators
Moving average 5 days
2,959.88
Moving average 20 days
2,884.54
Moving average 50 days
2,657.69
Moving average 100 days
2,499.35
Price spread / (MMA5)
+1.08%
Price spread / (MMA20)
-1.49%
Price spread / (MMA50)
-9.24%
Price spread / (MMA100)
-14.65%
STIM
RSI 9 days
56.17
RSI 14 days
60.62
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -2.27% | +3.87% | +100.36% | 5.3B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,024B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 663B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 453B | |
| -0.88% | +0.86% | +29.77% | +36.54% | 349B | |
| -10.89% | -14.63% | +9.27% | +26.87% | 295B | |
| -1.38% | -0.72% | -0.79% | +9.50% | 253B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 236B | |
| -2.32% | -0.65% | -15.84% | -56.91% | 206B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 187B | |
| Average | -3.35% | +0.01% | +21.50% | +48.71% | 367.26B | |
| Weighted average by Cap. | -2.42% | -1.04% | +32.66% | +57.34% |
Historical Quotes: GlaxoSmithKline Pharmaceuticals Limited
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
011f60eb5f6516ca1cb21.tEYz--9iog2GhrKKcsxKVS5oYHT0Hbs-KtF3p9qi-cM.8z5lj7Uu8ULz59b9AKsbOUYcBEGaUJZ9cosm6b34rajTMWGu2AnjZvL2gg
| Date | Price | Volume | Total |
|---|---|---|---|
| 06:21:28 | 2,928.20 | 1 | 50,684 |
| 06:20:29 | 2,928.20 | 5 | 50,683 |
| 06:20:12 | 2,928.20 | 2 | 50,678 |
| 05:59:58 | 2,934.00 | 3 | 50,676 |
| 05:59:47 | 2,930.40 | 10 | 50,673 |
| 05:59:32 | 2,935.00 | 1 | 50,663 |
| 05:59:16 | 2,935.90 | 1 | 50,662 |
| 05:59:08 | 2,935.90 | 1 | 50,661 |
Price Extremes
| 1 week | 2,921.2 |  | 3,075 |
| 1 month | 2,576.1 | | 3,120.7 |
| Current year | 2,088.1 | | 3,120.7 |
| 1 year | 2,088.1 | | 3,120.7 |
| 3 years | 1,385.05 | | 3,515.7 |
| 5 years | 1,227 | | 3,515.7 |
| 10 years | 962.65 | | 3,515.7 |
Monthly variations
Annual variations
| 2026 | +18.38% | ||
| 2025 | +9.85% | ||
| 2024 | +18.63% | ||
| 2023 | +43.94% | ||
| 2022 | -24.93% | ||
| 2021 | +8.17% | ||
| 2020 | +0.85% | ||
| 2019 | +6.27% | ||
| 2018 | +21.75% | ||
| 2017 | -8.81% | ||
| 2016 | -17.63% | ||
| 2015 | +3.61% | ||
| 2014 | +6.68% | ||
| 2013 | +38.29% | ||
| 2012 | +11.46% | ||
| 2011 | -16.79% | ||
| 2010 | +45.01% | ||
| 2009 | +40.09% | ||
| 2008 | +12.02% | ||
| 2007 | -11.67% | ||
| 2006 | +3.67% | ||
| 2005 | +45.67% | ||
| 2004 | +34.30% | ||
| 2003 | +87.85% | ||
| 2002 | +6.36% | ||
| 2001 | -37.14% | ||
| 2000 | +0.97% |
- Stock Market
- Stocks
- GLAXO Stock
- GLAXO Stock
- Quotes GlaxoSmithKline Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
